vs
Ascendis Pharma A/S（ASND）与RAYONIER ADVANCED MATERIALS INC.（RYAM）财务数据对比。点击上方公司名可切换其他公司
RAYONIER ADVANCED MATERIALS INC.的季度营收约是Ascendis Pharma A/S的1.6倍（$417.5M vs $267.3M），Ascendis Pharma A/S同比增速更快（42.3% vs -1.2%），过去两年Ascendis Pharma A/S的营收复合增速更高（60.7% vs 3.8%）
Ascendis Pharma A/S是一家聚焦内分泌疾病治疗领域的生物制药企业，核心业务覆盖生长激素疗法的研发、生产与商业化。其依托重组DNA技术生产的生长激素类处方药物，可用于治疗多种生长激素缺乏相关适应症，临床应用场景广泛。
RYAM（原雷尼尔先进材料公司）是一家美国全球性纤维素技术企业，主打高纯度特种纤维素产品，所生产的天然聚合物广泛应用于过滤器生产、食品加工、医药制造及各类工业领域，同时也为造纸和包装行业供应相关产品，在纤维素技术领域拥有较高的行业认可度。
ASND vs RYAM — 直观对比
营收规模更大
RYAM
是对方的1.6倍
$267.3M
营收增速更快
ASND
高出43.5%
-1.2%
两年增速更快
ASND
近两年复合增速
3.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $267.3M | $417.5M |
| 净利润 | — | $-21.1M |
| 毛利率 | 90.5% | 8.9% |
| 营业利润率 | — | 2.6% |
| 净利率 | — | -5.0% |
| 营收同比 | 42.3% | -1.2% |
| 净利润同比 | — | -31.9% |
| 每股收益（稀释后） | — | $-0.33 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASNDRYAM
| Q4 25 | $267.3M | $417.5M | ||
| Q3 25 | $230.7M | $352.8M | ||
| Q2 25 | $170.7M | $340.0M | ||
| Q1 25 | $109.0M | $356.0M | ||
| Q4 24 | $187.8M | $422.5M | ||
| Q3 24 | $62.5M | $401.1M | ||
| Q2 24 | $38.9M | $419.0M | ||
| Q1 24 | $103.6M | $387.7M |
净利润ASNDRYAM
| Q4 25 | — | $-21.1M | ||
| Q3 25 | $-65.9M | $-4.5M | ||
| Q2 25 | $-42.0M | $-363.2M | ||
| Q1 25 | $-102.2M | $-32.0M | ||
| Q4 24 | — | $-16.0M | ||
| Q3 24 | $-107.1M | $-32.6M | ||
| Q2 24 | $-118.1M | $11.4M | ||
| Q1 24 | $-141.5M | $-1.6M |
毛利率ASNDRYAM
| Q4 25 | 90.5% | 8.9% | ||
| Q3 25 | 89.5% | 9.7% | ||
| Q2 25 | 80.1% | 7.0% | ||
| Q1 25 | 82.6% | 6.8% | ||
| Q4 24 | 91.9% | 8.7% | ||
| Q3 24 | 80.6% | 10.9% | ||
| Q2 24 | 68.2% | 11.5% | ||
| Q1 24 | 92.1% | 9.5% |
营业利润率ASNDRYAM
| Q4 25 | — | 2.6% | ||
| Q3 25 | 5.1% | 2.8% | ||
| Q2 25 | -33.5% | -0.4% | ||
| Q1 25 | -103.2% | -4.2% | ||
| Q4 24 | — | 2.6% | ||
| Q3 24 | -167.3% | -4.2% | ||
| Q2 24 | -370.2% | 6.7% | ||
| Q1 24 | -51.2% | 4.4% |
净利率ASNDRYAM
| Q4 25 | — | -5.0% | ||
| Q3 25 | -28.5% | -1.3% | ||
| Q2 25 | -24.6% | -106.8% | ||
| Q1 25 | -93.7% | -9.0% | ||
| Q4 24 | — | -3.8% | ||
| Q3 24 | -171.5% | -8.1% | ||
| Q2 24 | -303.9% | 2.7% | ||
| Q1 24 | -136.6% | -0.4% |
每股收益（稀释后）ASNDRYAM
| Q4 25 | — | $-0.33 | ||
| Q3 25 | — | $-0.07 | ||
| Q2 25 | — | $-5.44 | ||
| Q1 25 | — | $-0.49 | ||
| Q4 24 | — | $-0.25 | ||
| Q3 24 | — | $-0.49 | ||
| Q2 24 | — | $0.17 | ||
| Q1 24 | — | $-0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $665.3M | $75.4M |
| 总债务越低越好 | — | $758.1M |
| 股东权益账面价值 | $-175.8M | $316.6M |
| 总资产 | $1.4B | $1.8B |
| 负债/权益比越低杠杆越低 | — | 2.39× |
8季度趋势，按日历期对齐
现金及短期投资ASNDRYAM
| Q4 25 | $665.3M | $75.4M | ||
| Q3 25 | $582.2M | $77.0M | ||
| Q2 25 | $533.6M | $70.7M | ||
| Q1 25 | $559.4M | $129.9M | ||
| Q4 24 | $604.3M | $125.2M | ||
| Q3 24 | $675.6M | $136.1M | ||
| Q2 24 | $279.4M | $114.1M | ||
| Q1 24 | $345.9M | $54.6M |
总债务ASNDRYAM
| Q4 25 | — | $758.1M | ||
| Q3 25 | — | $763.5M | ||
| Q2 25 | — | $720.4M | ||
| Q1 25 | — | $707.0M | ||
| Q4 24 | — | $706.4M | ||
| Q3 24 | — | $747.7M | ||
| Q2 24 | — | $752.8M | ||
| Q1 24 | — | $755.6M |
股东权益ASNDRYAM
| Q4 25 | $-175.8M | $316.6M | ||
| Q3 25 | $-188.0M | $338.2M | ||
| Q2 25 | $-202.6M | $342.3M | ||
| Q1 25 | $-205.0M | $688.1M | ||
| Q4 24 | $-114.2M | $713.9M | ||
| Q3 24 | $-105.1M | $732.7M | ||
| Q2 24 | $-346.8M | $755.1M | ||
| Q1 24 | $-257.2M | $741.8M |
总资产ASNDRYAM
| Q4 25 | $1.4B | $1.8B | ||
| Q3 25 | $1.2B | $1.8B | ||
| Q2 25 | $1.2B | $1.8B | ||
| Q1 25 | $1.1B | $2.1B | ||
| Q4 24 | $1.3B | $2.1B | ||
| Q3 24 | $1.2B | $2.2B | ||
| Q2 24 | $819.0M | $2.2B | ||
| Q1 24 | $866.7M | $2.1B |
负债/权益比ASNDRYAM
| Q4 25 | — | 2.39× | ||
| Q3 25 | — | 2.26× | ||
| Q2 25 | — | 2.10× | ||
| Q1 25 | — | 1.03× | ||
| Q4 24 | — | 0.99× | ||
| Q3 24 | — | 1.02× | ||
| Q2 24 | — | 1.00× | ||
| Q1 24 | — | 1.02× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $58.2M | $32.3M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ASNDRYAM
| Q4 25 | $58.2M | $32.3M | ||
| Q3 25 | — | $-17.8M | ||
| Q2 25 | — | $-30.2M | ||
| Q1 25 | $-15.5M | $39.6M | ||
| Q4 24 | $-330.7M | $54.9M | ||
| Q3 24 | — | $49.8M | ||
| Q2 24 | — | $87.6M | ||
| Q1 24 | $-109.7M | $11.3M |
现金转化率ASNDRYAM
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 7.69× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASND
暂无分部数据
RYAM
| Cellulose Specialties | $249.6M | 60% |
| Other | $86.2M | 21% |
| Paperboard | $44.2M | 11% |
| High Yield Pulp | $28.3M | 7% |
| Biomaterials | $9.2M | 2% |
